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Natural killer (NK) cells are motile cells that migrate between peripheral blood (PB), lymph
nodes (LNs), and various organs. Domestic animals have frequently been used to study
cellular migration, and offer unique opportunities for such studies. The aim of this study
was to characterize the phenotype and cytokine producing capacity of NK cells in bovine
skin-draining lymph. NKp46/NCR1+ CD3− cells constituted 2–11% of mononuclear cells in
afferent lymph (AL), a majority of cells were CD16+, CD8α+, and CD2−/low, and elevated
CD25 and CD44 expression indicated an activated phenotype. Interestingly, significantly
fewer AL NK cells expressed the early activation marker CD69 compared to PB NK cells. A
large proportion of lymph and blood NK cells produced interferon (IFN)-γ following stimu-
lation with IL-2 and IL-12. Notably, in AL, but not blood, a similar amount of IFN-γ+ NK cells
was observed when cells were stimulated with IL-12 alone. Overall, AL NK cells were more
similar to LN-residing NK cells than those circulating in PB. We conclude that AL appears
to be an important migration route for tissue-activated NK cells, and may represent an
alternative route for NK cell traffic to LNs. These findings may have important implications
in the development of adjuvant strategies that aim to target NK cells in a vaccine response.
Keywords: natural killer cells, afferent lymph, bovine, trafficking, activation, interferon-γ
INTRODUCTION
Natural killer (NK) cells are innate lymphocytes that act as early
responders during infection or inflammation by means of cytotox-
icity and production of immunoregulatory cytokines. Although
NK cells are found widely distributed in non-lymphoid and lym-
phoid tissues in human, mice, swine, and cattle (1–4), much is still
unknown regarding their recirculation and the chemokines and
homing molecules controlling these movements (5, 6).
During infection or inflammation, murine NK cells gain
increased entry from peripheral blood (PB) into lymph nodes
(LNs) via high-endothelial venules (HEVs). Interaction with acti-
vated dendritic cells (DCs) in the LN is believed to be important for
the priming of NK cells (7), upon which NK cells express the early
activation marker CD69 (8), but additional signals are needed for
NK cells to reach full activation and mediate effector functions
such as cytotoxicity and interferon (IFN)-γ production (9). NK
cells are believed to provide an early source of IFN-γ required for
a Th1 polarization of the immune response in vivo in mice (10, 11).
These events may be essential for the promotion of efficient Th1
targeting of vaccines (12). Since many vaccines are delivered to
the skin (intradermal or subcutaneous) understanding the func-
tion and phenotype of cells draining from this site can provide
important mechanistic insights to assist effective vaccine design
and delivery. Whilst a number of studies have focused on DC in
Abbreviations: AL, afferent lymph; FCM, flow cytometry; HEVs, high-endothelial
venules; LNs, lymph nodes; MFI, mean fluorescence intensity; PB, peripheral blood;
S1PR1, sphingosine-1-phosphate receptor 1.
this context little is currently understood about other innate cells
draining from the periphery.
The migration of NK cells from LNs via the efferent lymph, into
the PB and subsequent entry into inflamed tissue has been demon-
strated (2), but little is known of NK cell trafficking after entry
into tissues. Afferent lymphatics drain T cells and DCs from tissues
(13). The presence of NK cells has been reported in afferent lymph
(AL) draining the skin in humans (14, 15) and domestic animals
(16–18), but these cells have never been further characterized. In
human, AL was accessed by direct microsurgical cannulation of a
superficial lymphatic vessel (19, 20), giving access to cell popula-
tions originating from healthy normal skin (15, 21) and allergic
contact dermatitis affected skin (14). CD56+ cells were observed
in human AL at a significantly lower percentage than in PB (14,
15). A recent paper describes the presence of NKp46/NCR1+ cells
in seroma fluid believed to be an accumulation of AL (22). To
the authors’ knowledge, the three latter studies provide the only
observations of NK cells in human AL to date.
The method of pseudo-afferent lymphatic vessel cannulation
has been established in various animal models, including sheep
(23–25), cattle (17, 26), swine (27), and rat (28), and provides
a unique model that has generated a large body of our general
knowledge of lymphatic cellular migration from peripheral tis-
sues to the draining LN (23). The application of this model in
cattle enables the study of NK cells, which have been relatively well
characterized in this species (29, 30). Bovine NK cells, defined as
NKp46/NCR1+ CD3− lymphocytes, can be divided into a CD2+
subset dominating in PB and a CD2−/low subset dominating in LNs
www.frontiersin.org November 2013 | Volume 4 | Article 395 | 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lund et al. NK cells in afferent lymph
(31). The latter subset carry higher levels of CD16, CD8α, and
the activation markers CD25 and CD44, are particularly strong
IFN-γ producers, and dominate following in vitro stimulation
with IL-2 or IL-15 (32). Although the bovine subsets are not
directly comparable to humans, bovine CD2−/low NK cells to a
large extent resemble the CD56bright phenotype that dominates
in human lymphoid tissues in terms of function and distribution
(33, 34).
We here examined the phenotype and cytokine producing
capacity of NK cells in skin-draining AL under homeostatic condi-
tions,using a bovine cannulation model. AL NK cells were found in
a highly activated state and of a similar phenotype as LN-residing
NK cells, indicating that these cells may home to the LN. More
knowledge of the functional capacity and trafficking pattern of NK
cells in AL may help to illuminate central unanswered questions
about NK cell recirculation and their role in vaccine responses.
MATERIALS AND METHODS
ANIMALS
Animal experiments were carried out according to guidelines
of the UK Home Office and the Norwegian Animal Research
Authorities, with full ethics approval.
PB was taken from Norwegian Red (NR) dairy calves (Bos
taurus) of both sexes and 6–8 months of age, and collected in
EDTA-containing tubes. Animals were clinically healthy cattle
from a commercial Norwegian dairy farm. PB from Holstein–
Friesian calves at the Institute for Animal Health (IAH) was
collected by jugular venepuncture into sodium heparin (Leo
Pharma, UK).
Pseudo-AL vessel cannulations at IAH were carried out on
conventionally reared British Holstein–Friesian male calves. All
animals at IAH were aged between 6 months and 1 year. Paired
samples of PB and AL were obtained from one individual NR
male calf of 6–8 months of age. Repeated phenotyping and intra-
cellular IFN-γ analysis was performed on material collected from
this individual at 2–4 weeks after cannulation, and representative
results are included in this study.
SURGERY AND AFFERENT LYMPH COLLECTION
Pseudo-AL vessels were generated by surgical removal of super-
ficial cervical LNs and cannulations were performed essentially
as previously described (17). Briefly, approximately 8 weeks post-
lymphectomy, pseudo-AL vessels were surgically cannulated with
sterile, pre-siliconized, and heparinized portex tubing (Portex
Ltd.). Catheters were fixed in position, passed externally via a
skin incision and adequate flow of lymph was ensured. Lymph
was collected at various time points from day 3 to 28 post-surgery
into sterile plastic bottles containing heparin (10 U/ml), penicillin
(60µg/ml), and streptomycin (100µg/ml) (Gibco/Invitrogen),
and bottles were replaced every 8–12 h. Animals were injected
subcutaneously twice daily with heparin (0.5 ml, 2500 IU, GP
Pharmaceuticals) into a site draining to the catheterized lymph
vessel. The lymph collected was centrifuged (300× g, 8 min),
and AL cells were either used immediately in phenotypic or
functional studies or resuspended in FBS Gold (PAA, Pasching,
Austria) and 10% DMSO for storage in liquid nitrogen. Bovine
PBMC were isolated from EDTA or heparinized blood by density
gradient centrifugation (2210× g, 30 min) on lymphoprep (Axis-
Shield), and used immediately in phenotypic or functional
studies.
FLOW CYTOMETRY
Three-color flow cytometric (FCM) analysis of surface markers
or intracellular proteins was performed on isolated PBMC or on
fresh or previously frozen AL cells. Cells were first stained with
LIVE/DEAD® fixable far red dead cell stain for 633 excitation
(Invitrogen), following the manufacturer’s instructions. Subse-
quently, cells were surface labeled with in house produced primary
monoclonal antibodies (mAbs) against bovine NKp46/NCR1
[AKS1, IgG1 or AKS6, IgG2b; Ref. (32)], alone or in combina-
tion with mouse anti-bovine mAb against one of the following
molecules: CD3 (MM1A, IgG1), CD2 (MUC2A, IgG2a), CD8α
(BAQ111a, IgM), CD25 (CACT108A, IgG2a), CD44 (BAG40a,
IgG3), CD62L (BAQ92A, IgG1), CD69 (KTSN7A, IgG1) (all Mon-
oclonal Antibody Center, Washington State University, Pullman,
WA, USA), or mouse anti-human CD16 (KD1, IgG2a) (a kind gift
from Daniela Pende, ISTGE, Italy) or PE anti-human CCR7 (3D12,
rat IgG2a; BD Biosciences, USA). Secondary antibodies used
were polyclonal goat anti-mouse and were either PE-conjugated
(Southern Biotech, Birmingham, AL, USA) or Alexa Fluor 488-
conjugated (Invitrogen, Eugene, OR, USA). Cells surface labeled
with AKS1 were permeabilized and fixed (Cytofix/Cytoperm;
BD Biosciences), and further incubated with mouse anti-human
perforin (delta g9, IgG2b; BD Biosciences), followed by a PE-
conjugated secondary antibody. The method for intracellular
staining has been described in detail elsewhere (32). Gating was
based on stainings with secondary antibodies only or on non-
stimulated controls. Flowcytometry was performed with a FACS
Calibur flow cytometer and the CellQuest Pro software (BD Bio-
sciences), and expression was measured as % positive NK cells for
bimodal distributions and as mean fluorescence intensity (MFI)
for other distributions.
INTRACELLULAR IFN-γ ANALYSIS
For the detection of intracellular IFN-γ in NK cells, PBMC and
AL cells were added to 24-well plates at a concentration of 106
cells/well in 1 ml RPMI (Gibco/Invitrogen), with added penicillin,
streptomycin, and 10% FBS. Cells were incubated at 37°C and
with 5% CO2 for 24 h in medium only, or in the presence of
rbIL-2 (100 U/ml), rhIL-12 (400 pg/ml, eBioscience) or a com-
bination of the two cytokines, or in the presence of rhIL-15
(10 ng/ml, eBioscience) alone or in combination with rhIL-12.
Brefeldin A (10µg/ml, Sigma) was added to cells for the final
4 h of stimulation. Cells were stained with LIVE/DEAD® fix-
able far red dead cell stain, followed by surface staining against
NKp46/NCR1 (AKS6) and a secondary PE-conjugated Ab. Per-
meabilized and fixed cells were incubated with anti-bovine IFN-γ
mAb (clone 6, 19, IgG2a) (a kind gift from Gregers Jungersen
at the Technical University of Denmark) and secondary Alexa
488-conjugated antibody. Cells were analyzed by FCM on a FACS
Calibur.
STATISTICS
Differences between the groups were assessed by the non-
parametric Wilcoxon rank-sum test.
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RESULTS
PHENOTYPE OF EX VIVO NK CELLS
By using a model of bovine pseudo-AL vessel cannulation, we
examined the NK cell number and phenotype in skin-draining
lymph during the steady state. PBMC and AL cells were gated
on viable cells in a FSC/LIVE/DEAD plot and further gated on
mononuclear cells in a FSC/SSC plot (Figure 1A). Bovine NK cells
were defined as NKp46/NCR1+ CD3− cells (Figure 1B). NK cells
constituted 2–11% of mononuclear cells in AL, with a median
value of 4.6% (Figure 1C). In PBMC NK cells were present at 3–
18%, with a median value of 7.1%. These results show that PB was
significantly more NK cell rich than AL in cattle (p< 0.01).
Viable mononuclear cells from PBMC and AL were further
analyzed by FCM for the expression of NKp46/NCR1 in combina-
tion with other surface molecules. In AL, the majority of NK cells
were CD2−/low while around one third were CD2high (Figure 2A).
In contrast, a significantly higher proportion of the CD2high NK
cell population was found in PB (p< 0.01). Significantly more
(p< 0.05) NK cells from AL were CD8α+ compared to NK cells
from PB, although percentages of positive NK cells in AL were
highly variable between individuals (Figure 2B). The majority of
NK cells in AL and PB expressed CD16 (Figure 2C); however
there were significantly more CD16+ NK cells present within PB
compared to lymph (p< 0.001).
The expression of activation molecules CD44, CD25, and
CD69 on viable NK cells from the mononuclear cell fraction
was analyzed by FCM. The vast majority of NK cells in AL were
CD44bright with no NK cells being completely negative. By con-
trast in PB significantly fewer NK cells were CD44+ (median 40%,
p< 0.001),with the remaining population being CD44 dim to neg-
ative (Figure 3A). Striking differences in CD25 expression were
observed between the two compartments. A major CD25+NK
population was present in AL, while significantly fewer (p< 0.001)
CD25+ NK cells were present in PB where less than a third of
the NK cells expressed this molecule (Figure 3B). In AL, 14%
(10–40%) of cattle NK cells expressed the early activation marker
CD69, whereas in PB the median percentage of CD69 positive
NK cells was found to be significantly higher (p< 0.001) at 53%
(26–68%) (Figure 3C).
To determine whether skin-draining NK cells are equipped with
molecules that allow for LN recruitment, we assessed expression
of L-selectin (CD62L) and CCR7. CD62L was expressed on 48%
(24–73%) of AL and 59% (39–67%) of PB NK cells, and differ-
ences between the groups were not significant (not shown). CCR7
expression was not detected on bovine NK cells in PB or AL (not
shown).
Without prior stimulation, AL NK cells expressed intracellular
perforin with a median MFI value of 24 (21–28), whereas in PB
the median MFI value was found to be significantly higher at 49
(20–110, p< 0.05) (Figure 3D).
INTRACELLULAR IFN-γ PRODUCTION OF NK CELLS IN VITRO
To determine whether NK cells in AL were capable of producing
the effector cytokine IFN-γ, we stimulated PBMC and AL cells
in vitro with cytokines and stained for intracellular IFN-γ after
24 h. Viable mononuclear cells were analyzed by FCM. A large
proportion of PB (20–71%) and AL (32–86%) NK cells produced
FIGURE 1 | Natural killer (NK) cell distribution in peripheral blood and
afferent lymph from calves ex vivo. (A) Gating strategy illustrated by
representative density plots. Peripheral blood (PB) mononuclear and
afferent lymph (AL) cells were gated on viable cells in a FSC/LIVE/DEAD plot
(upper panels) and further gated on mononuclear cells in a FSC/SSC plot
(lower panels). (B) Representative density plots showing NKp46+/CD3− NK
cells in the upper left quartile and (C) distribution of the results showing NK
cells as a percentage of mononuclear cells in PB (n= 13) and AL (n=12).
Quadrants were based on control staining with secondary antibodies alone.
Symbols represent individual animals, where open symbols are
Holstein–Friesian and filled symbols are Norwegian Red. Filled triangles
identify one paired NR individual. Box plots show median and quartiles, and
whiskers indicate data points within the 1.5* (interquartile range).
Statistically significant differences between groups indicated as **p< 0.01.
IFN-γ following stimulation with IL-2 and IL-12 (Figure 4A).
Similar results were obtained when cells were stimulated with
IL-15 and IL-12 (not shown). In AL, a similar amount of IFN-
γ+ NK cells were observed upon stimulation with IL-12 only
(24–81%), whereas PB NK cells produced significantly less IFN-γ
under this stimulatory condition (9–52%, p< 0.05). This differ-
ence is illustrated in Figures 4B,C which show the percentage of
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FIGURE 2 | Phenotype of NK cells ex vivo. NK cell expression of the
surface molecules CD2 (A), CD8α (B), and CD16 (C). Gating of cells as in
Figure 1. Density plots (left panels) of representative animals from
peripheral blood (PB) and afferent lymph (AL). Numbers indicate the
percentage of NKp46+ cells above or below an expression threshold
(dashed line) for the indicated molecule. Distribution of the results (right
panels) showing % positive NK cells in PB (n=10–13) and AL (n=11–12).
Symbols and statistics as in Figure 1 (*p<0.05, ***p<0.001).
NKp46/NCR1+ IFN-γ+ cells in the mononuclear cell fraction in
all individuals (Figure 4B). IL-2 or IL-15 alone induced only mar-
ginally more IFN-γ+ NK cells compared to non-stimulated cells
in PB. AL NK cells, however, produced higher amounts of IFN-γ
compared to non-stimulated cells when stimulated with IL-2 or
IL-15 alone, although at a non-significant level (data not shown).
DISCUSSION
Although NK cells show a wide tissue distribution (2, 4, 35),
the mechanisms by which NK cells traffic through tissues at
steady state and following infection are not well characterized.
In this study we report the presence and phenotype of NK cells
in skin-derived AL from healthy cattle. Our results indicate an
alternative route of NK cell recruitment to LNs under physiologi-
cal conditions, not only from PB via HEV (10, 11), but also from
the AL.
Natural killer cells in AL showed a more activated (CD25+ and
CD44+) phenotype than NK cells in PB, and readily produced
IFN-γ upon in vitro stimulation, raising the question of where
and how these cells have been stimulated. The presence of CD56+
CD3− NK cells have been reported in human healthy (36, 37) and
lesional skin (38), and NK cells were observed in close contact with
DCs in vivo (36). A close cellular interaction of NK cells and DCs
or IL-2 producing T cells in tissues may possibly lead to a fur-
ther activation of NK cells recruited from PB. It cannot be totally
excluded that the activation observed in the current study could
be caused by inflammatory stimuli due to the invasive technique
used, but cells were only included after stabilization in the cellular
composition and animals were carefully monitored for the absence
of clinical signs of inflammation; conditions were in accordance
to standardized protocols for this technique (17, 24). Thus, the
CD2−/low CD25+ CD44+ phenotype of NK cells in bovine AL,
and the resemblance of these with LN-residing NK cells, suggest
that under non-inflammatory conditions, NK cells are activated
in the tissues, migrate through AL and enter the LNs, where they
constitute a large proportion of the residing NK cells.
Natural killer cells in the AL had a significantly lower expres-
sion of the early activation marker CD69 than NK in PB, despite
the presence of CD25 and potent IFN-γ production which indi-
cate that these cells are not naïve. They may represent a late phase
of activation, since in vitro, bovine NK cells express high levels of
CD69 after 6–12 h of stimulation, followed by a down-regulation
in later stages (32). It should also be noted that in T- and B-cells in
other species, CD69 is tightly linked to sphingosine-1-phosphate
receptor 1 (S1PR1) (39). The usage of S1P-receptors in bovine lym-
phocytes is not known and was not studied here due to limitation
of reagents for cattle. However, the observed expression pattern of
CD69 would be consistent with reports that this receptor is inter-
nalized together with S1PR1 in the S1P-rich lymphatic vessels (13),
followed by CD69 up-regulation in the S1P-free environment in
LNs, where CD69 inhibits S1PR1-mediated egress (40, 41). While
the mechanisms behind entry of NK cells from AL to LNs remain
to be studied, NK cell egress has been shown dependent on S1PR5
rather than S1PR1 in the mouse, in a process apparently resistant to
CD69 inhibition (42, 43). In line with this, we here and previously
(32) observed that CD69 is present on a substantial proportion of
cattle PB NK cells, although the migration history of these CD69+
PB NK cells needs to be clarified.
In human NK cells, CCR7 is present on the CD56bright sub-
set, and alleged responsible for their LN-homing, but absent on
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FIGURE 3 | Expression of activation molecules and intracellular perforin
in NK cells ex vivo. Expression of the activation molecules CD44 (A), CD25
(B), and CD69 (C) on NK cells. Gating of cells as in Figure 1. Density plots of
representative animals from peripheral blood (PB, left panels) and afferent
lymph (AL, middle panels). Numbers indicate the percentage of NKp46+ cells
above or below an expression threshold (dashed line) for the indicated
molecule. Distribution of the results (right panels) showing % positive NK
cells in PB (n=10–13) and AL (n=11–12). (D) Intracellular perforin in NK cells,
calculated as mean fluorescence intensity (MFI) of the NK cell population.
Histograms displaying representative animals from PB (left panel) and AL
(middle panel). Filled histograms indicate perforin expression and solid
histograms indicate the secondary control staining. Distribution of the results
(right panel) showing MFI of NK cells in PB (n=10) and AL (n=7). Symbols
and statistics as in Figure 1 (*p<0.05, ***p<0.001).
the CD56dim subset that dominates in PB (44). Here we could
not detect CCR7 expression on bovine NK cells in either PB or
AL, or on NK cells from LNs (Lund, unpublished observations)
when applying an anti-human CCR7 antibody cross-reactive to
bovine cells (45), even though we have previously found moderate
expression of mRNA transcripts for CCR7 by bovine NK cells in
PB (46) and high expression in LN-resident NK cells (Siddiqui
and Hope, unpublished observations). It remains a possibility
that post-transcriptional modification of CCR7 halts the surface
expression or interferes with antibody binding, and ideally these
results should be confirmed with a bovine-specific CCR7 antibody.
It was recently shown that bovine γd T cells egress from skin into
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FIGURE 4 | Interferon-γ producing capacity of NK cells from peripheral
blood and afferent lymph. (A) Flow cytometric analysis of intracellular IFN-γ
after 24 h of in vitro cytokine stimulation. Gating of cells as in Figure 1.
Density plots of representative animals from peripheral blood (left panels) and
afferent lymph (right panels). Numbers indicate IFN-γ+ NK cells (upper right
quartile) as percentage of all NK cells. (B,C) IFN-γ production of NK cells
following cytokine stimulation as in A with IL-2 and IL-12 or only IL-12.
Complete columns represent the total percentage of NKp46+ cells in the
mononuclear cell fraction, while the inner blue columns indicate the
percentage of NKp46+ IFN-γ+ cells in the same fraction. All individual animals
are presented with a unique ID, where numbers 1–10 are Norwegian Red and
11–18 are Holstein–Friesian. One paired NRF calf is underscored.
lymphatic vessels in a CCR7-independent manner (45), whilst the
entry of conventional murine and ovine αβ T cells into initial lym-
phatic vessels relies on CCR7 (47). The inability to detect CCR7
on bovine NK cells suggest that similar to bovine γd T cells, NK
cells may migrate in a CCR7-independent manner.
Natural killer cells are responsive to adjuvants (48) and may be
important players in vaccine responses (12, 49), underscoring the
relevance for harnessing the stimulation of NK cells when design-
ing vaccines. Examining afferent lymphatic NK cells draining the
sites of cutaneous vaccination will provide information as to the
induction of innate immune cell activation. This could be partic-
ularly important in the context of BCG vaccination and infection
with Mycobacteria where reciprocal interactions between DCs
and NK cells lead to enhanced Th1 bias and CD8+ T cell activation
that has been linked to vaccine efficacy (11, 50). Recent evidence
suggests that in humans effective BCG vaccination is dependent
upon innate (NK and gamma delta T) cell derived IFN-γ (51,
52), and ongoing studies assessing BCG vaccination and M. bovis
infection in cattle have revealed key roles for NK cells [Ref. (53)
and unpublished].
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The cost and complexity of the cannulation technique, which in
the present study was performed at two research sites, resulted in
a data material that may contain biasing factors. Steps were taken
to limit such confounders: Laboratory analyses were carried out
using standardized protocols by the same person, often repeated
several times. All animals were recruited from a similar age group
since age has proven to be a significant variable in NK cell biology
(54–56). Finally, no breed influence was detected in parameters
measured in PBMC (Figures 2 and 3). Only one NR dairy calf
was successfully catheterized, and since this individual had a high
number of NK cells in AL (Figure 1), attention should be paid to
a possible breed bias for this parameter. However, its exclusion did
not affect statistical or overall conclusions and it was thus included
here as an identifiable animal.
In conclusion, we here describe the presence of activated NK
cells in AL, suggesting a novel migration route for NK cells from
tissues into LNs. LNs may therefore not only be a site for prim-
ing of naïve NK cells recruited from PB at the initiation of an
immune response (7), but also a site for tissue-activated NK cells
arriving via AL that may contribute substantially to the shaping of
the adaptive immune response. Further studies of NK cell recir-
culation under vaccination or infection conditions are needed to
fully reveal mechanisms that can be utilized for optimal adjuvant
strategies in vaccine development.
ACKNOWLEDGMENTS
We wish to thank Dr. Bryan Charleston (The Pirbright Institute),
and Terje Fjeldaas and Cathrine Fjordbakk (Norwegian School
of Veterinary Science) for performing surgical procedures. Many
thanks to Grethe M. Johansen (Norwegian School of Veterinary
Science) and Paul Sopp (IAH) for technical assistance. We greatly
acknowledge the farm staff at IAH and the animal technicians at
the Norwegian Veterinary Institute for care of cattle, and Bygdø
Royal Manor for access to calves for blood sampling. This study was
funded by the Research Council of Norway (grant 183196/S40).
REFERENCES
1. Boysen P, Gunnes G, Pende D, Valheim M, Storset AK. Natural killer cells
in lymph nodes of healthy calves express CD16 and show both cytotoxic
and cytokine-producing properties. Dev Comp Immunol (2008) 32:773–83.
doi:10.1016/j.dci.2007.11.006
2. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, et al. The
trafficking of natural killer cells. Immunol Rev (2007) 220:169–82. doi:10.1111/
j.1600-065X.2007.00563.x
3. Mair KH, Essler SE, Patzl M, Storset AK, Saalmuller A, Gerner W. NKp46 expres-
sion discriminates porcine NK cells with different functional properties. Eur
J Immunol (2012) 42:1261–71. doi:10.1002/eji.201141989
4. Tomasello E, Yessaad N, Gregoire E, Hudspeth K, Luci C, Mavilio D, et al. Map-
ping of NKp46(+) cells in healthy human lymphoid and non-lymphoid tissues.
Front Immunol (2012) 3:344. doi:10.3389/fimmu.2012.00344
5. Carrega P, Ferlazzo G. Natural killer cell distribution and trafficking in human
tissues. Front Immunol (2012) 3:347. doi:10.3389/fimmu.2012.00347
6. Walzer T, Vivier E. G-protein-coupled receptors in control of natural killer cell
migration. Trends Immunol (2011) 32:486–92. doi:10.1016/j.it.2011.05.002
7. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells
prime natural killer cells by trans-presenting interleukin 15. Immunity (2007)
26:503–17. doi:10.1016/j.immuni.2007.03.006
8. Lanier LL, Buck DW, Rhodes L, Ding A, Evans E, Barney C, et al. Interleukin
2 activation of natural killer cells rapidly induces the expression and phos-
phorylation of the Leu-23 activation antigen. J Exp Med (1988) 167:1572–85.
doi:10.1084/jem.167.5.1572
9. Koka R, Burkett P, Chien M, Chai S, Boone DL, Ma A. Cutting edge: murine den-
dritic cells require IL-15R alpha to prime NK cells. J Immunol (2004) 173:3594–8.
10. Bajenoff M, Breart B, Huang AY, Qi H, Cazareth J, Braud VM, et al. Natural killer
cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med
(2006) 203:619–31. doi:10.1084/jem.20051474
11. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A,
et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for
T(H)1 priming. Nat Immunol (2004) 5:1260–5. doi:10.1038/ni1138
12. Lion E, Smits EL, Berneman ZN, Van Tendeloo VF. NK cells: key to suc-
cess of DC-based cancer vaccines? Oncologist (2012) 17:1256–70. doi:10.1634/
theoncologist.2011-0122
13. Forster R, Braun A, Worbs T. Lymph node homing of T cells and dendritic
cells via afferent lymphatics. Trends Immunol (2012) 33:271–80. doi:10.1016/j.
it.2012.02.007
14. Hunger RE, Yawalkar N, Braathen LR, Brand CU. The HECA-452 epitope is
highly expressed on lymph cells derived from human skin. Br J Dermatol (1999)
141:565–9. doi:10.1046/j.1365-2133.1999.03031.x
15. Yawalkar N, Hunger RE, Pichler WJ, Braathen LR, Brand CU. Human affer-
ent lymph from normal skin contains an increased number of mainly mem-
ory/effector CD4(+) T cells expressing activation, adhesion and co-stimulatory
molecules. Eur J Immunol (2000) 30:491–7. doi:10.1002/1521-4141(200002)30:
2<491::AID-IMMU491>3.0.CO;2-H
16. Crozat K, Guiton R, Contreras V, Feuillet V, Dutertre CA, Ventre E, et al. The XC
chemokine receptor 1 is a conserved selective marker of mammalian cells homol-
ogous to mouse CD8alpha+ dendritic cells. J Exp Med (2010) 207:1283–92.
doi:10.1084/jem.20100223
17. Hope JC, Howard CJ, Prentice H, Charleston B. Isolation and purification of
afferent lymph dendritic cells that drain the skin of cattle. Nat Protoc (2006)
1:982–7. doi:10.1038/nprot.2006.125
18. Van Rhiji I, Rutten VP, Charleston B, Smits M, van Eden W, Koets AP. Massive,
sustained gammadelta T cell migration from the bovine skin in vivo. J Leukoc
Biol (2007) 81:968–73. doi:10.1189/jlb.0506331
19. Brand CU, Hunziker T, Braathen LR. Isolation of human skin-derived lymph:
flow and output of cells following sodium lauryl sulphate-induced contact der-
matitis. Arch Dermatol Res (1992) 284:123–6. doi:10.1007/BF00372702
20. Engeset A, Hager B, Nesheim A, Kolbenstvedt A. Studies on human peripheral
lymph. I. Sampling method. Lymphology (1973) 6:1–5.
21. Olszewski WL, Grzelak I, Ziolkowska A, Engeset A. Immune cell traffic from
blood through the normal human skin to lymphatics. Clin Dermatol (1995)
13:473–83. doi:10.1016/0738-081X(95)00087-V
22. Montalto E, Mangraviti S, Costa G, Carrega P, Morandi B, Pezzino G, et al.
Seroma fluid subsequent to axillary lymph node dissection for breast can-
cer derives from an accumulation of afferent lymph. Immunol Lett (2010)
131:67–72. doi:10.1016/j.imlet.2010.03.002
23. Johnson LA, Jackson DG. Cell traffic and the lymphatic endothelium. Ann N Y
Acad Sci (2008) 1131:119–33. doi:10.1196/annals.1413.011
24. Schwartz-Cornil I, Epardaud M, Bonneau M. Cervical duct cannulation in sheep
for collection of afferent lymph dendritic cells from head tissues. Nat Protoc
(2006) 1:874–9. doi:10.1038/nprot.2006.147
25. Smith JB, McIntosh GH, Morris B. The traffic of cells through tissues: a study
of peripheral lymph in sheep. J Anat (1970) 107:87–100.
26. Emery DL, MacHugh ND, Ellis JA. The properties and functional activity of non-
lymphoid cells from bovine afferent (peripheral) lymph. Immunology (1987)
62:177–83.
27. Marquet F, Bonneau M, Pascale F, Urien C, Kang C, Schwartz-Cornil I, et al.
Characterization of dendritic cells subpopulations in skin and afferent lymph in
the swine model. PLoS One (2011) 6:e16320. doi:10.1371/journal.pone.0016320
28. Liu L, Zhang M, Jenkins C, MacPherson GG. Dendritic cell heterogeneity in vivo:
two functionally different dendritic cell populations in rat intestinal lymph can
be distinguished by CD4 expression. J Immunol (1998) 161:1146–55.
29. Boysen P, Storset AK. Bovine natural killer cells. Vet Immunol Immunopathol
(2009) 130:163–77. doi:10.1016/j.vetimm.2009.02.017
30. Storset AK, Kulberg S, Berg I, Boysen P, Hope JC, Dissen E. NKp46 defines a sub-
set of bovine leukocytes with natural killer cell characteristics. Eur J Immunol
(2004) 34:669–76. doi:10.1002/eji.200324504
31. Boysen P, Olsen I, Berg I, Kulberg S, Johansen GM, Storset AK. Bovine CD2-
/NKp46+ cells are fully functional natural killer cells with a high activation
status. BMC Immunol (2006) 7:10. doi:10.1186/1471-2172-7-10
www.frontiersin.org November 2013 | Volume 4 | Article 395 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lund et al. NK cells in afferent lymph
32. Lund H, Boysen P, Dean GA, Davis WC, Park KT, Storset AK. Interleukin-15 acti-
vated bovine natural killer cells express CD69 and produce interferon-gamma.
Vet Immunol Immunopathol (2012) 150:79–89. doi:10.1016/j.vetimm.2012.08.
011
33. Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, et al.
CD56bright natural killer cells are present in human lymph nodes and are acti-
vated by T cell-derived IL-2: a potential new link between adaptive and innate
immunity. Blood (2003) 101:3052–7. doi:10.1182/blood-2002-09-2876
34. Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, et al. The
abundant NK cells in human secondary lymphoid tissues require activation
to express killer cell Ig-like receptors and become cytolytic. J Immunol (2004)
172:1455–62.
35. Shi FD, Ljunggren HG, La CA, Van Kaer L. Organ-specific features of natural
killer cells. Nat Rev Immunol (2011) 11:658–71. doi:10.1038/nri3065
36. Buentke E, Heffler LC, Wilson JL, Wallin RP, Lofman C, Chambers BJ, et al.
Natural killer and dendritic cell contact in lesional atopic dermatitis skin –
Malassezia-influenced cell interaction. J Invest Dermatol (2002) 119:850–7.
doi:10.1046/j.1523-1747.2002.00132.x
37. Ebert LM, Meuter S, Moser B. Homing and function of human skin gam-
madelta T cells and NK cells: relevance for tumor surveillance. J Immunol (2006)
176:4331–6.
38. Ottaviani C, Nasorri F, Bedini C, de Pità O, Girolomoni G, Cavani A.
CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to
CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol (2006)
36:118–28. doi:10.1002/eji.200535243
39. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, Lanier LL, et al. CD69 acts down-
stream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from
lymphoid organs. Nature (2006) 440:540–4. doi:10.1038/nature04606
40. Bankovich AJ, Shiow LR, Cyster JG. CD69 suppresses sphingosine 1-phosophate
receptor-1 (S1P1) function through interaction with membrane helix 4. J Biol
Chem (2010) 285:22328–37. doi:10.1074/jbc.M110.123299
41. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, et al. Lym-
phocyte egress from thymus and peripheral lymphoid organs is dependent on
S1P receptor 1. Nature (2004) 427:355–60. doi:10.1038/nature02284
42. Jenne CN, Enders A, Rivera R, Watson SR, Bankovich AJ, Pereira JP, et al. T-bet-
dependent S1P5 expression in NK cells promotes egress from lymph nodes and
bone marrow. J Exp Med (2009) 206:2469–81. doi:10.1084/jem.20090525
43. Walzer T, Chiossone L, Chaix J, Calver A, Carozzo C, Garrigue-Antar L, et al. Nat-
ural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate
receptor. Nat Immunol (2007) 8:1337–44. doi:10.1038/ni1523
44. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc
Biol (2002) 71:173–83.
45. Vrieling M, Santema W, Van Rhiji I, Rutten V, Koets A. Gammadelta T cell hom-
ing to skin and migration to skin-draining lymph nodes is CCR7 independent.
J Immunol (2012) 188:578–84. doi:10.4049/jimmunol.1101972
46. Siddiqui N, Hope J. Differential recruitment and activation of natural killer
cell sub-populations by Mycobacterium bovis-infected dendritic cells. Eur
J Immunol (2013) 43:159–69. doi:10.1002/eji.201242736
47. Debes GF, Arnold CN, Young AJ, Krautwald S, Lipp M, Hay JB, et al. Chemokine
receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat
Immunol (2005) 6:889–94. doi:10.1038/ni1238
48. Magnusson SE, Reimer JM, Karlsson KH, Lilja L, Bengtsson KL, Stertman
L. Immune enhancing properties of the novel Matrix-M adjuvant leads to
potentiated immune responses to an influenza vaccine in mice. Vaccine (2013)
31:1725–33. doi:10.1016/j.vaccine.2013.01.039
49. Horowitz A, Behrens RH, Okell L, Fooks AR, Riley EM. NK cells as effec-
tors of acquired immune responses: effector CD4+ T cell-dependent acti-
vation of NK cells following vaccination. J Immunol (2010) 185:2808–18.
doi:10.4049/jimmunol.1000844
50. Vankayalapati R, Klucar P, Wizel B, Weis SE, Samten B, Safi H, et al. NK cells
regulate CD8+ T cell effector function in response to an intracellular pathogen.
J Immunol (2004) 172:130–7.
51. Watkins ML, Semple PL, Abel B, Hanekom WA, Kaplan G, Ress SR. Expo-
sure of cord blood to Mycobacterium bovis BCG induces an innate response
but not a T-cell cytokine response. Clin Vaccine Immunol (2008) 15:1666–73.
doi:10.1128/CVI.00202-08
52. Zufferey C, Germano S, Dutta B, Ritz N, Curtis N. The contribution of non-
conventional T cells and NK cells in the mycobacterial-specific ifngamma
response in bacille Calmette-Guerin (BCG)-immunized infants. PLoS One
(2013) 8:e77334. doi:10.1371/journal.pone.0077334
53. Siddiqui N, Price S, Hope J. BCG vaccination of neonatal calves: potential roles
for innate immune cells in the induction of protective immunity. Comp Immunol
Microbiol Infect Dis (2012) 35:219–26. doi:10.1016/j.cimid.2011.11.003
54. Elhmouzi-Younes J, Storset AK, Boysen P, Laurent F, Drouet F. Bovine neonate
natural killer cells are fully functional and highly responsive to interleukin-15
and to NKp46 receptor stimulation. Vet Res (2009) 40:54. doi:10.1051/vetres/
2009037
55. Graham EM, Thom ML, Howard CJ, Boysen P, Storset AK, Sopp P, et al. Natural
killer cell number and phenotype in bovine peripheral blood is influenced by
age. Vet Immunol Immunopathol (2009) 132:101–8. doi:10.1016/j.vetimm.2009.
05.002
56. Kulberg S, Boysen P, Storset AK. Reference values for relative numbers of
natural killer cells in cattle blood. Dev Comp Immunol (2004) 28:941–8.
doi:10.1016/j.dci.2004.02.004
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 28 August 2013; accepted: 07 November 2013; published online: 22 November
2013.
Citation: Lund H, Boysen P, Hope JC, Sjurseth SK and Storset AK (2013) Natural
killer cells in afferent lymph express an activated phenotype and readily produce IFN-γ .
Front. Immunol. 4:395. doi: 10.3389/fimmu.2013.00395
This article was submitted to NK Cell Biology, a section of the journal Frontiers in
Immunology.
Copyright © 2013 Lund, Boysen, Hope, Sjurseth and Storset . This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Immunology | NK Cell Biology November 2013 | Volume 4 | Article 395 | 8
